The 11th batch of national centralized drug procurement officially opened for bidding yesterday (27th) in Shanghai, according to the Shanghai Securities News.This batch of procurement has included a total of 55 kinds of drugs, mainly covering treatment areas such as anti-infection, anti-tumor, anti-allergy asthma, diabetes medication, cardiovascular medication, and the neurological system.Related NewsWUXI BIO (02269.HK) Up 5% as Nomura Says Reiterated Full-year Revenue Growth Guidance and Buyback Signal Undervaluation
AASTOCKS Financial News